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Recently, three large prospective trials unequivocally demonstrated that the evaluation of minimal residual disease (MRD) plays a pivotal role as a prognostic parameter in acute lymphoblastic leukemia (ALL). [1] [2] [3] Individualized therapeutic adaptations based on the MRD status might be of considerable benefit for ALL patients. Several methodologies are available for MRD analyses in ALL patients. [1] [2] [3] [4] Immunoglobulin (Ig) and T cell receptor (TCR) gene rearrangements have been utilized as PCR targets. An important PCR strategy for MRD analysis is the amplification of the rearranged Ig or TCR genes and hybridization with 32 P-labeled clone-specific probes in dot blot hybridization. Now that the relevance of MRD monitoring in ALL has been recognized, modification of current techniques or development of new techniques enabling rapid and reliable MRD analysis is relevant. We report on a non-radioactive dot blot analysis taking advantage of digoxigenin (DIG)-labeled oligonucleotides for the rapid detection of MRD. DIG is a steroid hapten which is linked via a spacer arm to a nucleotide. DIG-ddUTP is incorporated at the 3′-end of an oligonucleotide by terminal transferase. After hybridization, the target DNA is detectable by an enzyme-linked immunoassay through an anti-DIG-AP Fab fragment.
We applied this technique on 10 adult ALL patients with IGK and/or TCRD gene rearrangements. The patients were treated according to the German multicenter trial of ALL in adults 05/99. 5 High molecular weight DNA was prepared from bone marrow samples obtained at initial diagnosis using standard techniques. IGK and TCRD gene rearrangements were identified and characterized by PCR and sequencing as described. 6, 7 Oligonucleotides corresponding to the clonespecific junctional regions of the respective IGK/TCRD genes are shown in Table 1 .
Ten-fold serial dilutions of initial leukemic DNA into normal buffy coat (BC) DNA were prepared in a range from 10 −1 to 10 −6 . One g of each DNA preparation as well as BC DNA were amplified using a set of outer primers.
SDS solution at the hybridization temperature. The immunological detection was performed as follows. The membranes were soaked with blocking solution (0.1 M maleic acid, 0.15 M NaCl, 1% blocking reagent, pH 7.5) for 30 min at room temperature. Several membranes can be processed simultaneously in the same plastic box. The solution was discarded and 30 ml of blocking solution containing 6 l of anti-DIG-alkaline phosphatase Fab fragments (Roche Molecular Biochemicals) was added, followed by an additional incubation for 30 min. Finally, the membranes were washed twice with washing buffer (0.1 M maleic acid, 0.15 M NaCl, 0.3% Tween 20, pH 7.5) for 15 min and incubated with detection buffer (0.1 M Tris-HCl, 0.1 M NaCl, 50 mM MgCl 2 , pH 9.5) for 2 min. Each membrane was placed on a plastic hybridization bag and five drops of chemiluminescence substrate (CSPD ready-to-use, Roche Molecular Biochemicals) were added on to the surface of the membrane. The hybridization bags were sealed and incubated at 37°C for 10 min. Autography was performed using an X-OMAT DS film (Kodak) for 2-10 min. For the radioactive dot blot hybrization method, 20 pmol of each oligonucleotide was end-labeled with ␥-32 P-ATP using a T4 polynucleotide kinase (Amersham Pharmacia Biotech, Freiburg, Germany) at 37°C for 45 min. Hybridization and washing conditions were previously described. 6 The sensitivities for respective PCR targets using both methods are summarized in Table 1 and representative results are shown in Figure 1 . It can be concluded that the sensitivity of the DIG-based method was comparable to that of the radioactive dot blot hybridization method. Both methods allow the determination of the concentration of an unknown bone marrow follow-up sample.
There are alternative procedures for DIG-labeling of oligonucleotides such as 5′-labeling or 3′-tailing. However, the first method requires the addition of an aminolinker at the 5′ end of the oligonucleotide at the final step of the oligonucleotide synthesis. The second method adds a tail of 50 bp to the oligonucleotide which might reduce its specificity. Recently, a new labeling kit based on the direct labeling of oligonucleotides with AP via a 5′-aminolinker has become available, which makes the immunological step superfluous. Although the latter allows a more rapid detection of hybridized oligonucleotides, we decided to stick with the DIG oligonuclotide 3′-end labeling kit for economical reasons only (kit prices).
Compared to the radioactive method, the DIG-based method bears several advantages. Firstly, the procedure is non-radioactive and can therefore be performed in any routine laboratory. Secondly, due to the short exposure time (2-10 min) compared to that of the radioactive probe (12 h to several days), the whole procedure can be shortened considerably. Thirdly, end labeling of the oligonucleotide can be done at any time and the respective probes can be stored at −20°C until use. We routinely hybridize at an optimal concentration of 10 pmol/ml, implying that the labeled probe can be used up to four times considering a filter with a size of 25 cm 2 . Fourthly, the hybridization solution of DIG-labeled probes could be re-used several times, provided that the solution has been stored at −20°C. Hence, this method can save money as well as time. A minor disadvantage of the DIG-based method is that reduced signal intensity is sometimes observed due to overwashing after hybridization. Since it is possible to wash the filters repeatedly for optimal results, the first washing step should be performed under low stringency condition.
Recently, a fully automated system for the sequence-specific and semiquantitative detection of PCR products has been published. 8 The key to the system is the use of target-specific microbeads, incorporating covalently attached oligonucleotide probes. PCR samples are automatically analyzed using the precise fluid handling, temperature control and signal detection capabilities of the system. A great advantage of this system is that hybridization, washing and detection procedures are automated. Thus, laborious experiments for hybridization . can be omitted. However, its sensitivity and applicability for the evaluation of MRD in ALL has not been investigated yet.
Leukemia
Recent data obtained from a large series of childhood ALL strongly suggest that the time-points 1 and 3 months after induction therapy constitute critical parameters for the evaluation of therapeutic effectiveness. 3 The next challenge will be to test whether MRD-oriented therapeutic modifications can actually improve the outcome of ALL. Taking this task into consideration, a rapid and reproducible method is required. We think the DIG method fulfills these criteria.
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